Why was the G551D mutation selected for the VX-770 clinical trial?
The G551D mutation was the ideal mutation to start with because the protein from this mutation is located at the cell’s surface, waiting to function as a chloride channel. VX-770 acts to create a more effective opening of the CFTR chloride channel already at the cell surface. This makes the G551D mutation an obvious choice for studying VX-770.
